Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia   Report issue

Foundation Phase 1 Phase 2 Phase 3 Phase 4
Founded: Murcia Spain (2004)

Organization Overview

First Clinical Trial
2011
NCT01813201
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | HCUVA

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 1)

Carcinoma (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 3)

Fallopian Tube Neoplasms (Phase 3)

Heart Failure (Phase 4)

Hyperkinesis (Phase 4)

Ischemia (Phase 2)

Motor Neuron Disease (Phase 1)

Optic Nerve Diseases (Phase 2)

Optic Neuropathy, Ischemic (Phase 2)

Osteonecrosis (Phase 1)

Osteoporosis (Phase 1)

Ovarian Neoplasms (Phase 3)

Peritoneal Neoplasms (Phase 3)

Retinitis (Phase 1)

Retinitis Pigmentosa (Phase 1)

Sclerosis (Phase 1)

Spinal Fractures (Phase 1)

Urinary Bladder, Overactive (Phase 4)

Urinary Incontinence (Phase 4)

Urinary Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial APIs: 17